When Paul Wotton became CEO of Obsidian Therapeutics two years ago, he asked his team to explore where they could apply the company’s technology beyond cancer. Launched by Michael Gilman in 2017, the GV-backed company had been working on a way of controlling cell therapies after they’re administered to a patient, allowing doctors to modulate […]

A new initiative between MediOrbis, a telehealth provider specializing in chronic conditions, and DarioHealth Corp., a digital therapeutics company, offers older diabetics telehealth and remote patient monitoring. The program is geared to eligible Medicare beneficiaries. Initially accessing the new virtual care program will be Dario’s approximately 75,000 members with diabetes — of which 30% are […]

Dr James Woody discusses off-patent indications for anti-TNF to address unmet patient needs in pain, inflammation and beyond. The pro-inflammatory cytokine tumour necrosis factor (TNF) supports tissue homeostasis throughout the body, regulating its production and survival and apoptosis of cells. Inflammation and fibrosis are hallmarks of many clinical disorders. It was discovered that inflammatory diseases […]